(19)
(11) EP 2 262 772 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
13.03.2013 Bulletin 2013/11

(45) Mention of the grant of the patent:
18.07.2012 Bulletin 2012/29

(21) Application number: 09731679.8

(22) Date of filing: 16.04.2009
(51) International Patent Classification (IPC): 
C07D 215/20(2006.01)
C07D 405/12(2006.01)
C07D 413/12(2006.01)
A61K 31/4709(2006.01)
A61P 35/00(2006.01)
 C07D 401/12(2006.01)
C07D 409/12(2006.01)
A61K 31/407(2006.01)
A61K 31/506(2006.01)
(86) International application number:
PCT/EP2009/002798
(87) International publication number:
WO 2009/127417 (22.10.2009 Gazette 2009/43)

(54)

QUINOLINE DERIVATIVES AS AXL KINASE INHIBITORS

CHINOLINDERIVATE ALS AXL-KINASE-INHIBITOREN

DÉRIVÉS DE QUINOLINES UTILISÉS COMME INHIBITEURS DES KINASES AXL

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

(30) Priority: 16.04.2008 US 45398 P

(43) Date of publication of application:
22.12.2010 Bulletin 2010/51

(73) Proprietor: Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
80539 München (DE)

(72) Inventors:
  • ULLRICH, Axel
    80331 München (DE)
  • KNYAZEV, Pjotr
    82131 Stockdorf (DE)
  • ZHANG, Yixiang
    Brookline, MA 02446 (US)
  • GYÖRGY, Kéri
    H-1021 Budapest (HU)
  • ÖRFI, Lászlo
    H-1161 Budapest (HU)
  • SZABADKAI, István
    H-1186 Budapest (HU)

(74) Representative: Arth, Hans-Lothar 
ABK Patent Attorneys Jasminweg 9
14052 Berlin
14052 Berlin (DE)


(56) References cited: : 
WO-A-2005/030140
WO-A-2008/076415
 WO-A-2006/117552
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).